{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:51:25Z","timestamp":1787863885349,"version":"build-2784847793"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T00:00:00Z","timestamp":1700611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.anndiagpath.2023.152239","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T08:46:46Z","timestamp":1700642806000},"page":"152239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Prognostic implications of synaptophysin, CD56, thyroid transcription factor-1, and Ki-67 in pulmonary high-grade neuroendocrine carcinomas"],"prefix":"10.1016","volume":"68","author":[{"given":"Yulong","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinling","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.anndiagpath.2023.152239_bb0005","first-page":"989","article-title":"Chinese expert consensus on lung and thymus neuroendocrine neoplasms","volume":"43","author":"Expert Committee on Neuroendocrine Neoplasms","year":"2021","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"9","key":"10.1016\/j.anndiagpath.2023.152239_bb0010","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jtho.2022.07.006","article-title":"2021 WHO classification of lung cancer: a globally applicable and molecular biomarker-relevant classification","volume":"17","author":"Nicholson","year":"2022","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2023.152239_bb0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00428-020-03015-z","article-title":"Morphologic and molecular classification of lung neuroendocrine neoplasms","volume":"478","author":"Metovic","year":"2021","journal-title":"Virchows Arch"},{"issue":"10","key":"10.1016\/j.anndiagpath.2023.152239_bb0020","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.anndiagpath.2023.152239_bb0025","doi-asserted-by":"crossref","first-page":"1610730","DOI":"10.3389\/pore.2022.1610730","article-title":"Pulmonary large cell neuroendocrine carcinoma","volume":"28","author":"Yang","year":"2022","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.anndiagpath.2023.152239_bb0030","doi-asserted-by":"crossref","first-page":"215852","DOI":"10.1016\/j.canlet.2022.215852","article-title":"PARP inhibitor plus radioth- erapy reshapes an inflamed tumor microenvironment that sensitizes small cell lu- ng cancer to the anti-PD-1 immunotherapy","volume":"545","author":"Zhang","year":"2022","journal-title":"Cancer Lett"},{"issue":"7","key":"10.1016\/j.anndiagpath.2023.152239_bb0035","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1007\/s00268-017-3908-8","article-title":"Outcomes of curative intent surgery and adjuvant treatment for pulmonary large cell neuroendocrine carcinoma","volume":"41","author":"Kim","year":"2017","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.anndiagpath.2023.152239_bb0040","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/s41467-018-03099-x","article-title":"Integra- tive genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors","volume":"9","author":"George","year":"2018","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.anndiagpath.2023.152239_bb0045","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jtcvs.2012.03.036","article-title":"Immun- ohistochemical studies of pulmonary large cell neuroendocrine carcinoma: a possible association between staining patterns with neuroendocrine markers and tumor response to chemotherapy","volume":"145","author":"Tanaka","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.anndiagpath.2023.152239_bb0050","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.athoracsur.2014.10.015","article-title":"Predictors of surviv- al after operation among patients with large cell neuroendocrine carcinoma of the lung","volume":"99","author":"Eichhorn","year":"2015","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"10.1016\/j.anndiagpath.2023.152239_bb0055","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.humpath.2014.01.001","article-title":"A subset of small cell lung cancer with low neuroendocrine expression and good p- rognosis: a comparison study of su- rgical and inoperable cases with biopsy","volume":"45","author":"Hamanaka","year":"2014","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2023.152239_bb0060","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jso.25960","article-title":"Insulinoma- associated protein 1 is a prognostic biomarker in pulmonary high-grade neuroendocrine carcinoma","volume":"122","author":"Minami","year":"2020","journal-title":"J Surg Oncol"},{"issue":"9","key":"10.1016\/j.anndiagpath.2023.152239_bb0065","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","article-title":"The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification","volume":"10","author":"Travis","year":"2015","journal-title":"J Thorac Oncol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2023.152239_bb0070","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/1759-7714.14785","article-title":"Challenges of the eighth edition of the American Joint Committee on Cancer staging system for pathologists focusing on early stage lung adenocarcinoma","volume":"14","author":"Wang","year":"2023","journal-title":"Thorac Cancer"},{"issue":"2","key":"10.1016\/j.anndiagpath.2023.152239_bb0075","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.anndiagpath.2023.152239_bb0080","first-page":"522","article-title":"Prognostic and predictive value of thyroid transcription factor-1, CD56, P40 and other clinical characteristics in small cell lung cancer patients","volume":"20","author":"Wang","year":"2017","journal-title":"Zhongguo Fei Ai Za Zhi"},{"issue":"3","key":"10.1016\/j.anndiagpath.2023.152239_bb0085","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00432-022-03970-x","article-title":"Pulmonary neuroendocrine tumors: study of 266 cases focusing on clinicopathological characteristics, immunophenotype, and prognosis","volume":"149","author":"Zhang","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2023.152239_bb0090","first-page":"15","article-title":"Proliferation marker (Ki67) in sub-categorization of neuroendocrine tumours of the lung","volume":"35","author":"Garg","year":"2019","journal-title":"Turk Patoloji Derg"},{"issue":"8","key":"10.1016\/j.anndiagpath.2023.152239_bb0095","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-031531","article-title":"The utili- ty of Ki-67 as a prognostic biomarker in pulmonary neuroendocrine tumours: pr- otocol for a systematic review and meta-analysis","volume":"9","author":"Naheed","year":"2019","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.anndiagpath.2023.152239_bb0100","first-page":"2223","article-title":"Secretagogin, a marker for neuroendocrine cells, is more sensitive and specific in large cell neuroendocrine carcinoma compared with the markers CD56, CgA\uff0c Syn and Napsin A","volume":"19","author":"Dong","year":"2020","journal-title":"Oncol Lett"},{"issue":"7","key":"10.1016\/j.anndiagpath.2023.152239_bb0105","first-page":"547","article-title":"Analysis of correlation between TTF-1 and sensitivity to first-line chemotherapy and prognosis in patients with small cell lung cancer","volume":"23","author":"Wang","year":"2020","journal-title":"Zhongguo Fei Ai Za Zhi"},{"issue":"3","key":"10.1016\/j.anndiagpath.2023.152239_bb0110","doi-asserted-by":"crossref","first-page":"240","DOI":"10.29271\/jcpsp.2018.03.240","article-title":"Large cell carcinoma with adenocarcinoma in lung","volume":"28","author":"Kupeli","year":"2018","journal-title":"J Coll Physicians Surg Pak"},{"issue":"6","key":"10.1016\/j.anndiagpath.2023.152239_bb0115","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1053\/j.semdp.2015.10.009","article-title":"What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms?","volume":"32","author":"Pelosi","year":"2015","journal-title":"Semin Diagn Pathol"},{"issue":"15","key":"10.1016\/j.anndiagpath.2023.152239_bb0120","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.21037\/jtd.2017.01.60","article-title":"The role of surgery in high grade neuroendocrine tumours of the lung","volume":"9","author":"Welter","year":"2017","journal-title":"J Thorac Dis"},{"issue":"2","key":"10.1016\/j.anndiagpath.2023.152239_bb0125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/1878-0261.12608","article-title":"Comparative analysis of TTF-1 binding DNA regions in small-cell lung cancer and non-small-cell lung cancer","volume":"14","author":"Hokari","year":"2020","journal-title":"Mol Oncol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2023.152239_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13577-016-0149-3","article-title":"Small cell lung cancer, an epithelial to mesenchymal transition (EMT)-like cancer: significance of inactive Notch signaling and expression of achaete-scute complex homologue 1","volume":"30","author":"Ito","year":"2017","journal-title":"Hum Cell"},{"key":"10.1016\/j.anndiagpath.2023.152239_bb0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13000-015-0250-z","article-title":"Value of thyroid transcription factor (TTF)-1 for diagnosis and prognosis of patients with locally advanced or metastatic small cell lung cancer","volume":"10","author":"Misch","year":"2015","journal-title":"Diagn Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2023.152239_bb0140","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/1759-7714.12993","article-title":"Clinicopathological characteristics and prognostic factors of pulmonary large cell neuroendocrine carcinoma: a large population-based analysis","volume":"10","author":"Yang","year":"2019","journal-title":"Thorac Cancer"},{"issue":"7","key":"10.1016\/j.anndiagpath.2023.152239_bb0145","first-page":"1017","article-title":"On detection of chromogranin A, synaptophysin, neuronspecific enolase and progastrin-releasing peptide in small cell lung cancer","volume":"56","author":"Lu","year":"2022","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"issue":"6","key":"10.1016\/j.anndiagpath.2023.152239_bb0150","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cllc.2020.05.014","article-title":"Pemetrexed-based chemotherapy is inferior to pemetrexed-free regimens in thyroid transcription factor 1 (TTF-1)-negative, EGFR\/ALK-negative lung adenocarcinoma:a propensity score matched pairs analysis","volume":"21","author":"Frost","year":"2020","journal-title":"Clin Lung Cancer"},{"issue":"1","key":"10.1016\/j.anndiagpath.2023.152239_bb0155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1158\/1078-0432.CCR-17-1921","article-title":"Molecular subtypes of pulmonary large-cell neuroendocrine carcinoma predict chemotherapy treatment outcome","volume":"24","author":"Derks","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.anndiagpath.2023.152239_bb0160","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1158\/1078-0432.CCR-16-0355","article-title":"Genomic profiling of large cell neuroendocrine carcinoma of the lung","volume":"23","author":"Miyoshi","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.anndiagpath.2023.152239_bb0165","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.21037\/jtd.2019.04.56","article-title":"Efficacy of perioperative chemotherapy for pulmonary high-grade neuroendocrine carcinomas: a propensity score matching analysis","volume":"11","author":"Ogawa","year":"2019","journal-title":"J Thorac Dis"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913423001375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913423001375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:36:04Z","timestamp":1761078964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913423001375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":33,"alternative-id":["S1092913423001375"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2023.152239","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic implications of synaptophysin, CD56, thyroid transcription factor-1, and Ki-67 in pulmonary high-grade neuroendocrine carcinomas","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2023.152239","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152239"}}